CH117493A - Process for the preparation of p-N-B-methoxyethylaminobenzoic acid-B-piperidinoethyl ester. - Google Patents

Process for the preparation of p-N-B-methoxyethylaminobenzoic acid-B-piperidinoethyl ester.

Info

Publication number
CH117493A
CH117493A CH117493DA CH117493A CH 117493 A CH117493 A CH 117493A CH 117493D A CH117493D A CH 117493DA CH 117493 A CH117493 A CH 117493A
Authority
CH
Switzerland
Prior art keywords
acid
ester
preparation
methoxyethylaminobenzoic
piperidinoethyl
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellsc Farbenindustrie
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Publication of CH117493A publication Critical patent/CH117493A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

      Verfahren    zur     Darstellung    von     p-N-g-Methogyäthylaminobenzoesäure-          p-piperidinoäthylester.       Es wurde gefunden, dass man durch Ein  wirkung von     P-Halogenäthylmethyläther    auf       p-Aminobenzoesäure-p-piperidinoäthylester    zu  dem     p-N-P-Methoxyäthylaminobenzoesäure-R-          piperidinoäthylester    gelangt, der in Form seiner  Salze, wie umfangreiche Vergleichsversuche  der     Anmelderin    ergeben haben,

   bezüglich der  Stärke seiner Wirkung das Kokain um ein  Vielfaches     übertrifft.    Das neue Produkt ist ein  typisches Oberflächenanästhetikum und kommt  also für das grosse Gebiet der Schleimhaut  anästhesie in erster Linie in Frage. Der  basische Ester ist ein helles 01;

   das Chlor  hydrat besteht aus farblosen Kristallen vom  Schmelzpunkt<B>1380,</B> löst sich in Wasser mit  neutraler Reaktion und besitzt ein ausser  ordentlich starkes     Anästhesierungsvermögen.          Beispiel          Aequimolekulare        Mengen        p-Aminobenzoe-          säure-@-piperidinoäthylester    F. 90  (Deutsche  Patentschrift 172568 der Klasse 12 q) und       ss-Jodäthylmethyläther    Kp.     154-155     werden  zusammen 10 Stunden auf dem - Wasserbade    erhitzt. Danach wird das Produkt in Wasser  gelöst und die wenn nötig vom Ungelösten  filtrierte Lösung mit verdünnter Natrium  karbonatlösung übersättigt.

   Dadurch wird der       Alkaminester    als 01 abgeschieden, während  nebenher gebildete     quaternäre        Ammoniumsalze     in Lösung bleiben. Nach dem Aufnehmen in  Äther und Trocknen der Ätherlösung über       Kaliumkarbonat    erhält man durch fraktionierte  Destillation im Vakuum bei 4 mm Druck eine  oberhalb 200' siedende Fraktion, die mit der  für 1     Mol.    berechneten Menge Salzsäure in  Äthylalkohol versetzt auf Zugabe von Äther  erst öliges, aber bald fest werdendes p-N-,Q       Methoxyäthylaminobenzoesäure-ss-piperidino-          äthylestermonohydrochlorid    ergibt,

   das durch       Umkristallisieren    aus     Alkohol-Essigestermi-          sehung    rein vom Schmelzpunkt<B>1380</B> erhalten  wird.



      Process for the preparation of p-N-g-Methogyäthylaminobenzoäure- p-piperidinoäthylester. It has been found that an action of P-haloethyl methyl ether on p-aminobenzoic acid p-piperidinoethyl ester leads to the p-N-P-methoxyethylaminobenzoic acid R-piperidinoethyl ester, which in the form of its salts, as extensive comparative tests by the applicant have shown,

   exceeds cocaine many times over in terms of the strength of its effects. The new product is a typical surface anesthetic and is therefore primarily suitable for the large area of the mucosal anesthesia. The basic ester is a light 01;

   The chlorine hydrate consists of colorless crystals with a melting point of <B> 1380 </B>, dissolves in water with a neutral reaction and has an extremely strong anesthetic ability. Example Equimolecular amounts of p-aminobenzoic acid - @ - piperidinoethyl ester F. 90 (German patent 172568 class 12 q) and ß-iodoethyl methyl ether, boiling point 154-155, are heated together for 10 hours on the water bath. The product is then dissolved in water and the solution, filtered from undissolved material if necessary, is supersaturated with dilute sodium carbonate solution.

   As a result, the alkamine ester is deposited as oil, while quaternary ammonium salts formed at the same time remain in solution. After the ether solution has been taken up in ether and dried over potassium carbonate, fractional distillation in vacuo at 4 mm pressure gives a fraction boiling above 200 ', which is mixed with the amount of hydrochloric acid in ethyl alcohol calculated for 1 mol soon solidifying pN-, Q methoxyethylaminobenzoic acid-SS-piperidino ethyl ester monohydrochloride results,

   which is obtained by recrystallization from alcohol-ethyl acetate mixture with a purely melting point of <B> 1380 </B>.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung von p-N-ss Methogyäthylaminobenzoesäure-R-piperidino- äthylester, dadurch gekennzeichnet, dass man auf p-Aminobenzoesäure-p-piperidinoäthylester 13-Halogenäthylmethyläther einwirken lässt. Der basische Ester ist ein helles ()1, das Chlorhydrat besteht aus farblosen Kristallen vom Schmelzpunkt l38 , löst sich in Wasser mit neutraler Reaktion und besitzt ein ausser ordentlich starkes Anästhesierungsvermögen. PATENT CLAIM: Process for the preparation of p-N-ss methogyäthylaminobenzoic acid R-piperidino ethyl ester, characterized in that 13-haloethyl methyl ether is allowed to act on p-aminobenzoic acid p-piperidinoethyl ester. The basic ester is a light () 1, the chlorohydrate consists of colorless crystals with a melting point of 138, dissolves in water with a neutral reaction and has an extremely strong anesthetic ability.
CH117493D 1925-01-06 1925-01-06 Process for the preparation of p-N-B-methoxyethylaminobenzoic acid-B-piperidinoethyl ester. CH117493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH113055T 1925-01-06
CH117493T 1925-01-06

Publications (1)

Publication Number Publication Date
CH117493A true CH117493A (en) 1926-11-01

Family

ID=25708100

Family Applications (1)

Application Number Title Priority Date Filing Date
CH117493D CH117493A (en) 1925-01-06 1925-01-06 Process for the preparation of p-N-B-methoxyethylaminobenzoic acid-B-piperidinoethyl ester.

Country Status (1)

Country Link
CH (1) CH117493A (en)

Similar Documents

Publication Publication Date Title
DE2000030C3 (en) 3-alkoxy- and 3-phenoxy-2- (diphenylhydroxy) methyl-propylamines and medicaments containing them
DE2360318B2 (en) 1-PHENYL-2-PROPANONE DERIVATIVES AND THEIR PRODUCTION
CH117493A (en) Process for the preparation of p-N-B-methoxyethylaminobenzoic acid-B-piperidinoethyl ester.
DE527714C (en) Process for the preparation of soluble compounds of oxydiphenyl ethers or oxydiphenyl sulfides and their derivatives
DE897565C (en) Process for the preparation of aminoketones
DE1097995B (en) Process for the preparation of phenthiazine derivatives
DE894994C (en) Process for the production of aliphatic mercury ketone compounds
DE2605650A1 (en) PROCESS FOR THE PRODUCTION OF PARA-ISOBUTYL-PHENYL ACID DERIVATIVES
DE742650C (en) Process for the preparation of alkynediol ethers
AT158301B (en) Process for the production of vitamin B1.
DE431166C (en) Process for the preparation of alkamine esters of N-monoalkylated and N-monoalkyloxyalkylated derivatives of p-aminobenzoic acid
DE900933C (en) Process for the preparation of o-oxyarylcarboxylic acid-ª-naphthylamides
DE665510C (en) Process for the preparation of di- (p-phenetyl) - (2-aethoxypyridyl-5) -guanidine
AT225196B (en) Process for the preparation of the new 2,4-diamino-1-p-chlorophenyl-6,6-3&#39;-methylpentamethylene-1,6-dihydro-s-triazine and its acid addition salts
DE1568092C (en) Process for the preparation of new derivatives of 5,10 methano 5H dibenzo square brackets on a, square brackets on cycloheptens
AT204045B (en) Process for the production of new piperazine derivatives and their salts
AT33110B (en) Process for the preparation of alkyloxyacetyl compounds of alcohols of the hydroaromatic series.
DE575364C (en) Process for the production of water-soluble organic salts, in particular soaps
DE870121C (en) Process for the production of amines
AT49735B (en) Process for the preparation of derivatives of aromatic ammonium compounds.
AT155800B (en) Process for the production of diamino alcohols.
AT164547B (en) Process for the production of vitamin B1
DE24317C (en) Process for the preparation of the oxyhydrochinaldines and the methyl and ethyl derivatives thereof
DE2314676C3 (en) Process for the preparation of 2-phenyl-5-benzothiazolylacetic acid and its salts
AT44502B (en) Process for the preparation of a crystallized salicylosalicylic acid.